Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease

INTRODUCTION: The current therapeutic landscape of Alzheimer's disease (AD) is evolving rapidly. Our treatment options include new anti-amyloid-β protein disease-modifying therapies (DMTs) that decrease cognitive decline in patients with early AD (prodromal and mild AD dementia). Despite these...

Descripción completa

Detalles Bibliográficos
Autores principales: Saposnik, Gustavo, Sánchez-Benavidez, Gonzalo, García-Arcelay, Elena, Franco-Macías, Emilio, Bensi, Catalina, Carmelingo, Sebastián, Allegri, Ricardo F., Pérez-Martínez, David A., Maurino, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195934/
https://www.ncbi.nlm.nih.gov/pubmed/36952172
http://dx.doi.org/10.1007/s40120-023-00466-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195934/
https://www.ncbi.nlm.nih.gov/pubmed/36952172
http://dx.doi.org/10.1007/s40120-023-00466-9

Ejemplares similares